Retrospective validation of genomic biomarkers – what are the questions, challenges and strategies for developing useful relationships to clinical outcomes – workshop summary

作者: S-J Wang , N Cohen , D A Katz , G Ruano , P M Shaw

DOI: 10.1038/SJ.TPJ.6500363

关键词:

摘要: Retrospective validation of genomic biomarkers – what are the questions, challenges and strategies for developing useful relationships to clinical outcomes workshop summary

参考文章(3)
William L Trepicchio, Grant A Williams, David Essayan, Sue T Hall, Lea C Harty, Peter M Shaw, Brian B Spear, Sue Jane Wang, Mark L Watson, Pharmacogenomic data submissions to the FDA: clinical case studies Pharmacogenomics. ,vol. 5, pp. 519- 524 ,(2004) , 10.1517/14622416.5.5.519
Gualberto Ruaño, Jerry M Collins, Andrew J Dorner, Sue-Jane Wang, Roberto Guerciolini, Shiew-Mei Huang, Pharmacogenomic data submissions to the FDA: clinical pharmacology case studies. Pharmacogenomics. ,vol. 5, pp. 513- 517 ,(2004) , 10.1517/14622416.5.5.513
Lawrence J. Lesko, Ronald A. Salerno, Brian B. Spear, Donald C. Anderson, Timothy Anderson, Celia Brazell, Jerry Collins, Andrew Dorner, David Essayan, Baltazar Gomez-Mancilla, Joseph Hackett, Shiew-Mei Huang, Susan Ide, Joanne Killinger, John Leighton, Elizabeth Mansfield, Robert Meyer, Stephen G. Ryan, Virginia Schmith, Peter Shaw, Frank Sistare, Mark Watson, Alexandra Worobec, Pharmacogenetics and pharmacogenomics in drug development and regulatory decision making: report of the first FDA-PWG-PhRMA-DruSafe Workshop. The Journal of Clinical Pharmacology. ,vol. 43, pp. 342- 358 ,(2003) , 10.1177/0091270003252244